Toate aceste legume ar trebui sa fie bio/organice
These participants incorporated MCT oil into their diet, following a tolerance-based regimen of twice-daily supplementation for a three-month period
509 After 8 weeks, the patients mucosal healing increased significantly, and symptoms such as rectal bleeding were significantly relieved
Primary Targets GLP-1 Glucagon Research Areas Dual receptor biology Energy metabolism Experimental metabolic pathways Emerging obesity research NovaSyn Labs currently supplies: 10 mg Mazdutide Mazdutide is another emerging peptide attracting attention within European research communities
Anthropic CEO Amodei denies seeking ban on open-weight AI models ANTHROToday, 12:27 AM Materion declares $0.145 dividend MTRN +0.33%Today, 12:23 AM Banco Latinoamericano declares $0.6875 dividend BLX -0.34%Today, 12:22 AM Applied Digital expects $1B NOI run rate a year from now as contracted lease value reaches $36B APLD -3.00%Today, 12:19 AM Ryanair deepens AWS ties with 5-year deal for cloud and agentic AI AMZN -0.31%Today, 12:14 AM F5 forecasts 9%-10% FY 2026 revenue growth as Q4 EPS guidance targets $4.14-$4.26 FFIV +4.02%Yesterday, 11:29 PM Navitas projects $13.5M Q3 revenue while targeting AI infrastructure at more than 1/3 of sales by year-end NVTS +4.49%Yesterday, 9:59 PM Sanmina targets $16B+ revenue in FY 2027 as it guides Q4 EPS of $3.05-$3.35 SANM +0.23%Yesterday, 9:39 PM Opko outlines $560M-$585M 2026 revenue guidance while planning MDX3001 clinical start by end of 2026 or early 2027 OPK +1.64%Yesterday, 9:29 PM Agilysys targets $368M-$373M FY 2027 revenue and at least 32% subscription growth following Q1 guidance raise AGYS +4.77%Yesterday, 8:19 PM Happen forecasts $1.80 to $1.90 EPS for 2026 amid raised originations target to $12.2B to $12.6B HAPN +3.82%Yesterday, 8:19 PM DoE issued emergency order for Southwest Power Pool grid to deploy backup power AEP -1.44%Yesterday, 8:18 PM5 Comments Kforce forecasts Q3 revenue of $349M-$357M and EPS of $0.71-$0.79 as technology demand improves KFRC +5.46%Yesterday, 8:10 PM Johnson & Johnson to pay up to $5.5B to settle talc lawsuits JNJ +0.97%Yesterday, 8:01 PM13 Comments Amkor projects Q3 2026 revenue of $1.95B-$2.05B with EPS of $0.72-$0.82 as Computing nears 30% sequential growth AMKR -6.54%Yesterday, 7:40 PM1 Comment Cadence signals 19% 2026 revenue growth amid record $8.1B backlog and expanding agentic AI partnerships CDNS +3.79%Yesterday, 7:39 PM Crude oil plunges after U.S
Dosage Adjustments: Significant weight loss often means you need less thyroid medication
